Itamar Shimrat - Cell Source CEO
| CLCS Stock | USD 0.0002 0.40 99.95% |
CEO
Mr. Itamar Shimrat is Chief Executive Officer, Chief Financial Officer, Director of the Company. A Canadian businessman and a founding member of Cell Source. Since Cell Source Israel inception, Mr. Shimrat served as a Director, Chief Financial Officer and, in October 2013, he was appointed Chief Executive Officer. Previously, Mr. Shimrat served as an Executive Vice President and Division Head at First International Bank of Israel, where he founded and led the strategic planning function, including planning, strategy, strategic marketing branding and project management oversight functions. He led a successful rebranding and repositioning of the bank and during his tenure the bank ROE was doubled. Previously, Mr. Shimrat worked as an international management consultant, chiefly at McKinsey Co., and he led successful major profit improvement programs for top tier financial institutions including Barclays in England and the Commonwealth Bank of Australia. He began his management consulting career at Bain Company, where he participated in the development of a new global retail strategy for Citibank. He holds an MBA with Distinction from the Ivey Business School of the University of Western Ontario in Canada. since 2014.
| Age | 64 |
| Tenure | 10 years |
| Professional Marks | MBA |
| Phone | 646 416 7896 |
| Web | https://www.cell-source.com |
Cell Source Management Efficiency
The company has return on total asset (ROA) of (3.7761) % which means that it has lost $3.7761 on every $100 spent on assets. This is way below average. Cell Source's management efficiency ratios could be used to measure how well Cell Source manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CEO Age | ||
| Brian Pedlar | Covalon Technologies | N/A | |
| Gilles Gagnon | Ceapro Inc | 62 | |
Management Performance
| Return On Asset | -3.78 |
Cell Source Leadership Team
Elected by the shareholders, the Cell Source's board of directors comprises two types of representatives: Cell Source inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cell. The board's role is to monitor Cell Source's management team and ensure that shareholders' interests are well served. Cell Source's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cell Source's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yoram Drucker, Executive Chairman | ||
| Ben Friedman, Director | ||
| Dennis Brown, Director | ||
| David Zolty, Director | ||
| Itamar Shimrat, CEO and President CFO, Principal Accounting Officer and Director | ||
| BSc MA, Ex Chairman |
Cell Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Cell Source a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -3.78 | |||
| Current Valuation | 59.65 M | |||
| Shares Outstanding | 35.25 M | |||
| Shares Owned By Insiders | 32.13 % | |||
| Price To Earning | (3.28) X | |||
| EBITDA | (4.11 M) | |||
| Net Income | (5.47 M) | |||
| Cash And Equivalents | 93.09 K | |||
| Total Debt | 6.5 M | |||
| Debt To Equity | (1.04) % |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cell Source in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cell Source's short interest history, or implied volatility extrapolated from Cell Source options trading.
Pair Trading with Cell Source
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cell Source position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cell Source will appreciate offsetting losses from the drop in the long position's value.Moving against Cell Pink Sheet
| 0.64 | SGEN | Seagen Inc Earnings Call Tomorrow | PairCorr |
The ability to find closely correlated positions to Cell Source could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cell Source when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cell Source - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cell Source to buy it.
The correlation of Cell Source is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cell Source moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cell Source moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cell Source can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cell Source. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Cell Source information on this page should be used as a complementary analysis to other Cell Source's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Cell Pink Sheet analysis
When running Cell Source's price analysis, check to measure Cell Source's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cell Source is operating at the current time. Most of Cell Source's value examination focuses on studying past and present price action to predict the probability of Cell Source's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cell Source's price. Additionally, you may evaluate how the addition of Cell Source to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |